Nadroparin

Known as: Nadroparin Calcium, Nadroparin [Chemical/Ingredient], Nadroparine 
A low molecular weight heparin (LMWH) composed of a heterogeneous mixture of sulfated polysaccharide glycosaminoglycan chains obtained by… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2018
0102019922018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
BACKGROUND Aspirin and low-molecular-weight heparin are prescribed for women with unexplained recurrent miscarriage, with the… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Clinical trials are needed to assess the clinical benefit of antithrombotic prophylaxis in patients with cancer who… (More)
  • figure 1
  • table 1
  • table 4
  • table 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
OBJECTIVE Continuous venovenous hemofiltration (CVVH) is applied in critically ill patients with acute renal failure for renal… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2007
2007
BACKGROUND In this non-randomized study we aimed to assess the efficacy of the addition of low molecular weight heparin (LMWH) to… (More)
Is this relevant?
2006
2006
BACKGROUND The optimal thromboprophylactic dosage regimen of low-molecular-weight heparins in high-risk general surgery remains… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE Studies in cancer patients with venous thromboembolism suggested that low molecular weight heparin may prolong survival… (More)
Is this relevant?
2001
2001
PURPOSE The purpose of this study was to evaluate whether low molecular weight heparin (LMWH) could be equal or more effective… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Low molecular weight heparins are as effective as unfractionated heparin in deep-vein thrombosis (DVT) prophylaxis for major… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND AND PURPOSE Treatment of cerebral sinus thrombosis with heparin is controversial. We conducted a double-blind, placebo… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
1995
1995
The present trial was designed to comparatively investigate the pharmacokinetic profile and evaluate the apparent bioavailability… (More)
Is this relevant?